Secondary Chromosome Changes in Mantle Cell Lymphoma: Cytogenetic and Fluorescence in situ Hybridization Studies

References

• Argatoff L. H., Connors J. M., Klasa R. J., Horsman D. E., Gascoyne R. D. Mantle cell lymphoma: a clinicopathologic study of 80 cases. Blood 1996; 89: 2067
   Web of Science ®Google Scholar
• Vaandrager J. W., Schuuring E., Zwikstra E., de Boer C. J., Kleiverda K. K., van Krieken J. H.J.M., Kluin-Nelemans H. C., van Ommen G. J.B., Raap A. K., Kluin P. M. Direct visualization of dispersed 11q13 chromosomal traslocations in mantle cell lymphoma by multi-color DNA fiber FISH. Blood 1996; 88: 1177
   PubMed Web of Science ®Google Scholar
• Bigoni R., Negrini M., Veronese M. L., Cuneo A., Castoldi G., Croce C. M. Characterization of t(11;14) translocation in mantle cell lymphoma by fluorescent in situ hybridization. Oncogene 1996; 13: 797
   PubMed Web of Science ®Google Scholar
• Hinds P. W., Dowdy S. F., Eaton E. N., Arnold A., Weinberg R. A. Function of a human cyclin gene as an oncogene. Procedures of Natural Academy Sciences USA 1994; 91: 709
   PubMed Web of Science ®Google Scholar
• Lovec H., Grzeschiczek A., Kowalsky M. B., Moroy T. Ciclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice. EMBO Journal 1994; 13: 3487
   PubMed Web of Science ®Google Scholar
• Stilgenbauer S., Nickolenko J., Wilhelm J., Wolf S., Weitz S., Fisher K., Boehm T., Dohner H., Lichter P. Expressed sequences as candidates for a novel tumor suppressor gene at abnd 13q14 in B-cell chronic lymphocytic leukemia and mantle cell lymphoma. Oncogene 1998; 16: 1891
   PubMed Web of Science ®Google Scholar
• Cuneo A., Bigoni R., Negrini M., Bullrich F., Veronese M. L., Roberti M. G., Bardi A., Rigolin G. M., Cavazzini P. L., Croce C. M., Castoldi G. L. Cytogenetic and interphase cytogenetic characterization of atypical chronic lymphocytic leukemia carryng BCL1 translocation. Cancer Research 1997; 57: 1144
   PubMed Web of Science ®Google Scholar
• Stilgenbauer S., Winkler D., Ott G., Schaffner C., Leupolt E., Bentz M., Möller P., Müller-Hermelink H. K., James M. R., Lichter P., Döhner H. Molecular Characterization of 1 1q Deletions Points to a Pathogenic Role of the ATM Gene in Mantle Cell Lymphoma. Blood 1999; 94: 3262–3264
   PubMed Web of Science ®Google Scholar
• Cuneo A., Bigoni R., Rigolin G. M., Roberti M. G., Bardi A., Piva N., Milani R., Bullrich F., Veronese M. L., Croce C., Birg F., Dohner H., Hagemeijer A., Castoldi G. L. Cytogenetic profile of lymphoma of follicle mantle lineage: correlation with clinicobiological features. Blood 1999; 93: 1372–1380
   PubMed Web of Science ®Google Scholar
• Harris N. L., Jaffe E. S., Stein H., Banks P. M., Chan J. K.C., Cleary M. L., Delsol G., de Wolf-Peeters C., Falini B., Gatter K. C., Grogan T. M., Isaacson P. G., Knowles D. M., Mason D. Y., Muller-Hermelink H. K., Pileri S. A., Piris M. A., Ralfkiaer E., Warnke R. A. A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood 1994; 84: 1361
   PubMed Web of Science ®Google Scholar
• ISCN. Guidelines for cancer cytogenetics. Supplement to An International System for Human Cytogenetic Nomenclature, F. Mitelman. Basel, Karger 1995
   Google Scholar
• Vandenberghe E., de Wolf-Peeters C., Van Den Oord J., Wlodarska I., Delabie J., Stul M., Thomas J., Michaux J. L., Mecucci C., Cassiman J. J., Vandenberghe H. Translocation (11;14): a cytogenetic anomaly associated with B cell lymphomas of non-follicle centre cell lineage. Journal of Patholology 1991; 163: 13
   Web of Science ®Google Scholar
• Leroux D., Le Marc' hardour F., Gressin R. Non Hodgkin's lymphomas with t(11;14)(q13;q32): a subset of mantle zone/intermediate lymphocytic lymphoma. British Journal of Haematol 1991; 7: 346
   Web of Science ®Google Scholar
• Nowotny H., Karlic H., Gruner H., Hirsch J., Vesely M., Nader A., Heinz R. Cytogenetic findings in 175 patients indicates that items of the Kiel classification should not be disregarded in the REAL classification of lymphoid neoplasms. Annals of Hematology 1996; 72: 291
   PubMed Web of Science ®Google Scholar
• Siebert R., Matthiesen P., Harder S., Zhang Y., Borowski A., Zuhlke-Jenisch R., Plendl H., Metzke S., Joos S., Zucca E., Weber-Matthiesen K., Roggero E., Grote W., Schlegelberger B. Application of interphase cytogenetics for the detection of t(11;14)(q13;q32) in mantle cell lymphomas. Annals of Oncology 1998; 9: 519
   PubMed Web of Science ®Google Scholar
• Wlodarska I., Pittaluga S., Hagemeijer A., de Wolf-Peeters C., Van Den Berghe H. Secondary chromosome changes in mantle cell lymphoma. Haematologica 1999; 84: 594–599
   PubMed Web of Science ®Google Scholar
• Monni O., Oinonen R., Elonen E., Franssila K., Teerenhovi L., Joensu H., Knuutila S. Gain of 3q and deletion of 11q22 are frequent aberrations in mantle cell lymphoma. Genes, Chromosomes and Cancer 1998; 21: 298
   PubMed Web of Science ®Google Scholar
• Beà S., Ribas M., Hernàndez J.M., Bosch F., Pinyol M., Hernàndez L., Garcia J. L., Flores T., Gonzàles M., Lòpez-Guillermo A., Piris M. A., Cardesa A., Montserrat E., Mirò R., Campo E. Increased number oc chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants. Blood 1999; 93: 4365–4374
   PubMed Web of Science ®Google Scholar
• Offitt K., Wong G., Philippa D. A., Tao Y., Chaganti R. S.K. Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: clinical correlations. Blood 1991; 77: 1508
   PubMed Web of Science ®Google Scholar
• Tilly H., Rossi A., Stamatoullas A., Lenormand B., Bigorgne C., Kunlin A., Monconduit M., Bastard C. Prognostic value of chromosomal abnormalities in follicular lymphoma. Blood 1994; 84: 1043
   PubMed Web of Science ®Google Scholar
• Johansson B., Mertens F., Mitelman F. Primary vs. secondary neoplasia-associated chromosomal abnormalities-Balanced rearrangements vs. genomic imbalances?. Genes, Chromosomes and Cancer 1996; 16: 155–163
   PubMed Web of Science ®Google Scholar
• Johansson B., Mertens F., Mitelman F. Cytogenetic evolution patterns in non-Hodgkin's lymphoma. Blood 1995; 86: 3905
   PubMed Web of Science ®Google Scholar
• Dohner H., Stilgenbauer S., Fisher K., Bentz M., Lichter P. Cytogenetic and molecular cytogenetic analysis of B cell chronic lymphocytic leukemia: specific chromosome aberrations identify prognostic subgroups of patients and point to loci of candidate genes. Leukemia 1997; 11: 19–24
   PubMed Web of Science ®Google Scholar
• Cuneo A., Bigoni R., Rigolin G. M., Roberti M. G., Bardi A., Campioni D., Minotto C., Agostini P., Milani R., Bullrich F. Croce, Castoldi C. G.L. 13q14 deletion in non-Hodgkin's lymphoma: correlation with clinicopathological features. Haematologica 1999; 84: 589–593
   PubMed Web of Science ®Google Scholar
• Louie D. C., Offit K., Jaslow R., Parsa N. Z., Murty V. V.V.S., Schluger A., Chaganti R. S.K. p53 overexpression as a marker of poor prognosis in mantle cell lymphoma with t(11;14)(q13;q32). Blood 1995; 86: 2892
   PubMed Web of Science ®Google Scholar
• Cabanillas E., Pathak S., Grant G., Hagermeister F. B., McLaughlin P., Swan E., Rodriguez M. A., Trujillo J., Cork A., Butler J. J., Katz R., Bourne S., Freireich E. J. Refractoriness to chemotherapy and poor survival related to abnormalities of chromosomes 17 and 7 in lymphoma. American Journal of Medicine 1989; 87: 167
   PubMed Web of Science ®Google Scholar
• Levine E. G., Arthur D. C., Frizzera G., Peterson B. A., Hurd D. D., Bloomfield CD. Cytogenetic abnormalities predict clinical outcome in non-Hodgkin's lymphoma. Annals of Internal Medicine 1988; 108: 14
   PubMed Web of Science ®Google Scholar
• Greiner T. C., Moynihan M. J., Chan W. C., Lytle D. M., Pedersen A., Anderson J. R., Weisenburger D. D. p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis. Blood 1996; 87: 4302
   PubMed Web of Science ®Google Scholar
• Sankar M., Tanaka K., Kumaravel T. S., Arif M., Shintani T., Yagi S., Kyo T., Dohy H., Kamada N. Identification of a commonly deleted region at 17p13.3 in leukemia and lymphoma associated with 17p abnormality. Leukemia 1998; 12: 510–516
   PubMed Web of Science ®Google Scholar
• Callet-Bauchu E., Salles G., Gazzo S., Poncet C., Morel D., Pagès J., Coiffer B., Coeur P., Felman P. Translocation involving the short arm of chromosome 17 in chronic B-lymphoid disorders: frequent occurence of dicentric rearrangements and possible association with adverse outcome. Leukemia 1999; 13: 460–468
   PubMed Web of Science ®Google Scholar
• Stilgenbauer S., Bullinger L., Benner A., Wildenberger K., Bentz M., Döhner K., Ho A. D., Lichter P., Döhner H. Incidence and clinical significance of 6q deletions in B cell chronic lymphocytic leukemia. Leukemia 1999; 13: 1331–1334
   PubMed Web of Science ®Google Scholar
• Juliusson G., Gahrton G., Oscier D., Fitchett M., Ross E. M., Brito-Babapulle V., Catovsky D., Knuutila S., Elonen E., Lechleitner M., Tanzer J., Schoenwald M., Castoldi G. L., Cuneo A., Nowell P., Peterson L., Kay N. Cytogenetic findings and survival in B-cell chronic lymphocytic leukemia. Secnd IWCCLL compilation data on 662 patients. Leukemia and Lymphoma 1991; 2(suppl 1)21–25
   Web of Science ®Google Scholar
• Gaidano G., Hauptschein R. S., Parsa N. Z., Offit K., Rao P. H., Lenoir G., Knowles D. M., Chaganti R. S.K., Dalla Favera R. Deletions involving two distinct regions of 6q in B cell non-Hodgkin lymphoma. Blood 1992; 80: 1781–1787
   PubMed Web of Science ®Google Scholar
• Guan X. Y., Horsman D., Zhang H. E., Parsa N. Z., Meltzer P. S., Trent J. M. Localization by chromosome microdissection of a recurrent breakpoint region on chromosome 6 in human B cell lymphoma. Blood 1996; 88: 1418–1422
   PubMed Web of Science ®Google Scholar
• Zhang Y., Matthiesen P., Harder S., Siebert R., Castoldi G., Calasanz M. J., Wong K. F., Rosenwald A., Ott G., Atkin N. B., Schlegelberger B. A 3-cM Commonly Deleted Region in 6q21 in Leukemias and Lymphomas Delineated by Fluorescence In Situ Hybridization. Genes, Chromosomes and Cancer 2000; 27: 52–58
   PubMed Web of Science ®Google Scholar
• Pyniol M., Hernandez L., Cazorla M., Balbin M., Jares P., Fernandez P. L., Montserrat E., Cardesa A., Lopez-Otin C., Campo E. Deletions and loss of expression of P16INK4a and P21Waf1 genes are associates with aggressive variants of mantle cell lymphoma. Blood 1997; 89: 272–280
   PubMed Web of Science ®Google Scholar
• Gnønbaek K., Nedergaard T., Andersen M. K., Thor Styraten P., Guldberg P., Møller P., Zuethen J., Ebbe Hansen N., Hou-Jensen K., Ralfkiaer E. Concurrent disruption of cell cycle associated genes in mantle cell lymphoma: a genotipic and phenotypic study of cyclin D1, p16, p15, p53 and pRb. Leukemia 1998; 12: 1266–1271
   PubMed Web of Science ®Google Scholar
• Garcia-Sans R., Vargas Montero M., Gonzalez Diaz M., Chillòn Santos, Balanzategui M.d.C., Echevarria A., Flores Corral T., Hernàndez Martin J. M., Caballero Barrigon M. D., San Miguel J. F. Detection of single and associated lesions of the Bcl-1, Bcl-2, Bcl-6, c-myc, p53 and p16 genes in b-cell non-Hodgkin's lymphomas: value of molecular analysis for a better assignment of the hystologic subtype. Haematologica 1998; 83: 209–216
   PubMed Web of Science ®Google Scholar
• Dreyling M. H., Bullinger L., Ott G., Stilgenbauer S., Muller-Hermelink H. K., Bentz M., Hiddemann W., Dohner H. Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma. Cancerer Research 1997; 57: 4608
   PubMed Web of Science ®Google Scholar
• Mitelman E. Catalog of chromosome aberrations 5th edn. Wiley-Liss. 1994
   Google Scholar
• Vandenberghe E., de Wolf-Peeters C., Wlodarska I. Chromosome 11q rearrangements in B non Hodgkin's lymphoma. British Journal of Haematology 1992; 81: 212–219
   PubMed Web of Science ®Google Scholar
• Willis T. G., Jadayel D. M., Du M. Q., Peng H., Perry A. R., Abdul-Rauf M., Price H., Karran L., Majekodumni O., Wlodarska I., Pan L., Crook T., Hamoudi R., Isaacson P. G., Dyer M. J.S. BCL10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell 1999; 96: 35–45
   PubMed Web of Science ®Google Scholar
• Stankovic T., Weber P., Stewart G., Bedenham T., Murray J., Byrd P. J., Moss P. A.H., Taylor A. M.R. Inactivation of ataxia telagiectasia mutated gene in B-cell chronic lymphocytic leukaemia. Lancet 1999; 353: 26
   PubMed Web of Science ®Google Scholar